Pneumolysin Mediates Platelet Activation In Vitro

被引:0
作者
Jan Gert Nel
Chrisna Durandt
Timothy J. Mitchell
Charles Feldman
Ronald Anderson
Gregory R. Tintinger
机构
[1] University of Pretoria and Tshwane Academic Division of the National Health Laboratory Service,Department of Haematology, Faculty of Health Sciences
[2] University of Pretoria,Institute for Cellular and Molecular Medicine, and SAMRC Extramural Unit for Stem Cell Research and Therapy, Department of Immunology, Faculty of Health Sciences
[3] University of Pretoria,Department of Internal Medicine, Faculty of Health Sciences
[4] University of Birmingham,Institute of Microbiology and Infection, College of Medical and Dental Sciences
[5] University of the Witwatersrand,Division of Pulmonology, Department of Internal Medicine, Faculty of Health Sciences, and Charlotte Maxeke Academic Hospital
来源
Lung | 2016年 / 194卷
关键词
Calcium; CD62P; Community-acquired pneumonia; Pneumococcus; P-selectin;
D O I
暂无
中图分类号
学科分类号
摘要
This study has explored the role of the pneumococcal toxin, pneumolysin (Ply), in activating human platelets. Following exposure to Ply (10–80 ng/ml), platelet activation and cytosolic Ca2+ concentrations were measured flow cytometrically according to the level of expression of CD62P (P-selectin) and spectrofluorimetrically, respectively. Exposure to Ply resulted in marked upregulation of expression of platelet CD62P, achieving statistical significance at concentrations of 40 ng/ml and higher (P < 0.05), in the setting of increased influx of Ca2+. These potentially pro-thrombotic actions of Ply were attenuated by depletion of Ca2+ from the extracellular medium or by exposure of the cells to a pneumolysoid devoid of pore-forming activity. These findings are consistent with a mechanism of Ply-mediated platelet activation involving sub-lytic pore formation, Ca2+ influx, and mobilization of CD62P-expressing α-granules, which, if operative in vivo, may contribute to the pathogenesis of associated acute lung and myocardial injury during invasive pneumococcal disease.
引用
收藏
页码:589 / 593
页数:4
相关论文
共 63 条
[1]  
Welte T(2012)Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality Eur J Clin Microbiol Infect Dis 31 33-47
[2]  
Steel HC(2013)Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease Mediators Inflamm 2013 490346-103
[3]  
Cockeran R(2015)Interleukin-1β participates in the development of pneumococcal acute lung injury and death by promoting alveolar microvascular leakage J Bacteriol Virol 45 93-165
[4]  
Anderson R(2007)The association between pneumococcal pneumonia and acute cardiac events Clin Infect Dis 45 158-159
[5]  
Bong Y(2009)Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes Medicine (Baltimore) 88 154-781
[6]  
Shin SG(2012)Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality Circulation 125 773-301
[7]  
Koh SH(2014)Cardiac diseases complicating community-acquired pneumonia Curr Opin Infect Dis 27 295-1954
[8]  
Musher DM(2006)Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia Crit Care Med 34 1947-1762
[9]  
Rueda AM(2007)Role of platelet-activating factor in pneumolysin-induced acute lung injury Crit Care Med 35 1756-635
[10]  
Kaka AS(2007)The role of pneumolysin in mediating lung damage in a lethal pneumococcal pneumonia murine model Respir Res 8 3-8782